Visit WTR Logo
Click here to see our best subscription offers

Market Developments

The world's top IP dealmakers and value creators identified – part three

We reveal who is listed in positions 20 to 11 in this year's IAM Market Makers ranking of the individuals who drive the global IP market.

The world's top IP dealmakers and value creators identified – part three
21 Sep 2018

The world's top IP dealmakers and value creators identified – part two

We reveal who is listed in positions 30 to 21 in this year's IAM Market Makers ranking of the individuals who drive the global IP market.

21 Sep 2018

New firm backed by TCL is latest corporate foray into IP consulting services

Chinese electronics major’s general counsel will chair the new independent service provider. China is still showing strong demand for high-level IP strategy advice.

Latest

View all
20 Sep 2018

The rise of biosimilars and the future of healthcare intellectual property

Litigation between rights holders of biologic drugs and producers of biosimilars is set to become an increasingly important part of the life sciences IP landscape Read more

18 Sep 2018

Swedish eye tracking leader sues to curb Chinese upstart

IBM patent asserted against Beijing-based startup with backing from HTC and Qualcomm. NPEs are also active in a possible new VR/AR battleground. Read more

17 Sep 2018

Latest quarterly numbers show patent deal activity dropping to lowest level in two years

Exclusive analysis from AST highlights lull in the secondary market. Seiko, Sony and GE feature among top sellers; while Longitude Licensing and RPX lead the way on buyside.  Read more

14 Sep 2018

Broad Institute wins crucial CRISPR decision at CAFC, but patent battle with University of California is far from over

The Federal Circuit’s judgment in favour of Broad in a much-anticipated CRISPR case is unlikely to bring the hard-fought patent dispute with its West Coast rival to an end just yet. Read more

News

View all
13 Sep 2018

Fortress’s burgeoning IP group adds Tivo patent dealmaker

The hire of Courtney Quish and the closing of an investment fund thought to be close to $1 billion in value adds even more heft to the team headed by Eran Zur Read more

21 Aug 2018

Nokia reveals expected licensing rate for 5G phones

Finnish mobile giant joins rivals Ericsson and Qualcomm in announcing royalty, although likes of Apple, Samsung and Huawei may pay much less for new generation of devices.  Read more

8 Aug 2018

Just a week after the US mid-term elections, the 4th Patent Law and Policy event couldn't be more timely

The fourth annual Patent Law and Policy event returns to Washington DC in November. It will take place just after a vote that will affect key IP policymakers in the US Congress. Read more

5 Aug 2018

NPEs like Sisvel have survived the storm - that's another reason why the deals market is picking up

A series of recent deals from Italian licensing business show that some patent owners are prospering in current climate.  Read more

Analysis

View all
11 Sep 2018

‘No timeline’ for 5G rate disclosure, Huawei IP chief tells IAM

In an exclusive interview, Jason Ding explains why aggregate royalties may come down in the 5G era and suggests that announcing rates now would be jumping the gun. Read more

10 Sep 2018

It’s not done yet, but Trump trade deal could herald IP breakthrough for pharma innovators in Mexico

With a major focus on intellectual property, the new US-Mexico trade agreement may provide stronger data protection and patent rights Read more

4 Sep 2018

Predictions of 2018 pharma M&A surge fall flat, but patent licensing deals are at a record high

Despite forecasts of a sharp rise in pharma deal-making activity, it has proved to be a slow year on the M&A front. One reason may be that licensing partnerships are proving far more popular than many had expected. Read more

24 Aug 2018

SCOTUS petition on HIV drug patents poses reputational as well as legal risks for pharma companies

An HIV/AIDS non-profit organisation is seeking a change in the law surrounding patent invalidity lawsuits. Read more

Insights

View all
29 Mar 2018

A deal for our times

InterDigital’s acquisition of Technicolor’s licensing business was a patent blockbuster and says much about the current state of the monetisation market Read more

1 Dec 2017

Going global is the new mantra in the patent transactions market

A record-breaking deal between Nokia and Provenance Asset Group shows just how important multinational patent portfolios now are to the patent buy-side Read more

1 Aug 2017

Litigation cools in the United States, while the political action hots up

The first six months of the year saw a continuing decline in patent litigation in the United States, although the same cannot be said for political developments in June and July Read more

1 Feb 2017

IAM names its IP personalities of 2016

There is little doubt that last year was among the most momentous of recent times – in intellectual property as in so many other areas. That made choosing our IP personalities of 2016 a tough task Read more

Trending

1

Fortress’s burgeoning IP group adds Tivo patent dealmaker

2

‘No timeline’ for 5G rate disclosure, Huawei IP chief tells IAM

3

Latest quarterly numbers show patent deal activity dropping to lowest level in two years

4

Size of drug patent thickets highlighted by report, amidst intense pharma IP scrutiny

5

Predictions of 2018 pharma M&A surge fall flat, but patent licensing deals are at a record high

Find an expert

Hui Zhang
Partner
Beijing, China
ZY Partners
View full biography
We use cookies on www.iam-media.com. By using this site, you agree that we may store and access cookies on your device. For further information please read our cookie policy and our terms and conditions.